Hydroxyprogesterone caproate

Hydroxyprogesterone Caproate is a synthetic progestational agent similar to the endogenous progesterone used in hormone therapy or as a female contraceptive. Mimicking the action of progesterone, hydroxyprogesterone caporate binds to and activates nuclear progesterone receptors in the reproductive system and causes the ligand-receptor complex to be translocated to the nucleus where it binds to and promotes expression of target genes. Due to the negative feedback mechanism seen with progesterone, this agent also blocks luteinizing hormone (LH) release from the pituitary gland, thereby leading to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. Furthermore, without stimulation of LH, estrogen release from the ovaries is stopped, hence impeding the growth of estrogen-sensitive tumor cells. It is grouped under the following drug class(es): Hormones and Progestins. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Delalutin and Primolut Depot. Its PubChem CID is 169870.

CAS No 630-56-8
Molecular Formula C27H40O4
Molecular Weight 428.6 g/mol
Synonyms [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate

Frequently Asked Questions